Cargando…

Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells

BACKGROUND: The purpose of the research is to investigate the roles of Jak-STAT3 signaling pathway in bufalin-induced apoptosis in colon cancer SW620 cells. METHODS: The inhibitory effects of bufalin on cell proliferation were determined by MTT (Methyl thiazolyltetrazolium) assay. The morphological...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhitu, Li, Enze, Liu, Yangyang, Gao, Yu, Sun, Hongzhi, Ma, Guangyou, Wang, Zhenghua, Liu, Xiaomei, Wang, Qingjun, Qu, Xiujuan, Liu, Yunpeng, Yu, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534604/
https://www.ncbi.nlm.nih.gov/pubmed/23110625
http://dx.doi.org/10.1186/1477-7819-10-228
_version_ 1782475364928323584
author Zhu, Zhitu
Li, Enze
Liu, Yangyang
Gao, Yu
Sun, Hongzhi
Ma, Guangyou
Wang, Zhenghua
Liu, Xiaomei
Wang, Qingjun
Qu, Xiujuan
Liu, Yunpeng
Yu, Yunlong
author_facet Zhu, Zhitu
Li, Enze
Liu, Yangyang
Gao, Yu
Sun, Hongzhi
Ma, Guangyou
Wang, Zhenghua
Liu, Xiaomei
Wang, Qingjun
Qu, Xiujuan
Liu, Yunpeng
Yu, Yunlong
author_sort Zhu, Zhitu
collection PubMed
description BACKGROUND: The purpose of the research is to investigate the roles of Jak-STAT3 signaling pathway in bufalin-induced apoptosis in colon cancer SW620 cells. METHODS: The inhibitory effects of bufalin on cell proliferation were determined by MTT (Methyl thiazolyltetrazolium) assay. The morphological changes of cells were measured by Wright-Giemsa staining. The cell cycle arrest and apoptosis were tested by flow cytometry analysis. Western Blot was used to determine the protein expression of the apoptosis inhibitors livin and caspase-3, the apoptosis-related proteins Bax and Bcl-2, as well as the key protein kinases in the Jak-stat3 signaling pathway, stat3 and p-stat3. RESULTS: (1) Bufalin inhibited the proliferation of SW620 cells. IC50 at 24 h, 48 h and 72 h were 76.72 ± 6.21 nmol/L, 34.05 ± 4.21 nmol/L and 16.7 ± 6.37 nmol/L. (2) Bufalin induced SW620 cell cycle arrest and apoptosis, indicated by the appearance of apoptotic bodies; (3) The results from flow cytometry demonstrated that there was cell cycle G2/M phase arrest in 20 nmol/L bufalin treatment group (36.29 ± 2.11% vs 18.39 ± 1.74%, P<0.01); there was a sub-diploid apoptosis peak in 80 nmol/L bufalin treatment group (19.69 ± 1.63% vs 0.99 ± 0.23%, P <0.01). The apoptosis rate was 34.63 ± 2.57% (vs 19.69 ± 1.63%, P = 0.002) in JAK kinase inhibitor AG490 plus bufalin treatment group. (4) During the process of bufalin-induced apoptosis in SW620 cells, transient activation of p-stat3 inhibited the activation of stat3, up-regulated Bax expression, down-regulated livin and Bcl-2 expression (P<0.01), and activated caspase-3. Inhibition of Jak-stat3 signaling pathway by pre-treatment with AG490 significantly enhanced the bufalin-induced apoptosis (P<0.01), further up-regulated Bax protein expression, down-regulated livin and Bcl-2 protein expression and enhanced caspase-3 activation. CONCLUSIONS: Bufalin not only inhibited the growth of colon cancer SW620 cells, but also induced apoptosis of SW620 cells. Activation of caspase-3, up-regulation of Bax, down-regulation of livin and Bcl-2, as well as inhibition of Jak-stat3 signaling pathway might be the important mechanisms for the bufalin-induced apoptosis.
format Online
Article
Text
id pubmed-3534604
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35346042013-01-03 Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells Zhu, Zhitu Li, Enze Liu, Yangyang Gao, Yu Sun, Hongzhi Ma, Guangyou Wang, Zhenghua Liu, Xiaomei Wang, Qingjun Qu, Xiujuan Liu, Yunpeng Yu, Yunlong World J Surg Oncol Research BACKGROUND: The purpose of the research is to investigate the roles of Jak-STAT3 signaling pathway in bufalin-induced apoptosis in colon cancer SW620 cells. METHODS: The inhibitory effects of bufalin on cell proliferation were determined by MTT (Methyl thiazolyltetrazolium) assay. The morphological changes of cells were measured by Wright-Giemsa staining. The cell cycle arrest and apoptosis were tested by flow cytometry analysis. Western Blot was used to determine the protein expression of the apoptosis inhibitors livin and caspase-3, the apoptosis-related proteins Bax and Bcl-2, as well as the key protein kinases in the Jak-stat3 signaling pathway, stat3 and p-stat3. RESULTS: (1) Bufalin inhibited the proliferation of SW620 cells. IC50 at 24 h, 48 h and 72 h were 76.72 ± 6.21 nmol/L, 34.05 ± 4.21 nmol/L and 16.7 ± 6.37 nmol/L. (2) Bufalin induced SW620 cell cycle arrest and apoptosis, indicated by the appearance of apoptotic bodies; (3) The results from flow cytometry demonstrated that there was cell cycle G2/M phase arrest in 20 nmol/L bufalin treatment group (36.29 ± 2.11% vs 18.39 ± 1.74%, P<0.01); there was a sub-diploid apoptosis peak in 80 nmol/L bufalin treatment group (19.69 ± 1.63% vs 0.99 ± 0.23%, P <0.01). The apoptosis rate was 34.63 ± 2.57% (vs 19.69 ± 1.63%, P = 0.002) in JAK kinase inhibitor AG490 plus bufalin treatment group. (4) During the process of bufalin-induced apoptosis in SW620 cells, transient activation of p-stat3 inhibited the activation of stat3, up-regulated Bax expression, down-regulated livin and Bcl-2 expression (P<0.01), and activated caspase-3. Inhibition of Jak-stat3 signaling pathway by pre-treatment with AG490 significantly enhanced the bufalin-induced apoptosis (P<0.01), further up-regulated Bax protein expression, down-regulated livin and Bcl-2 protein expression and enhanced caspase-3 activation. CONCLUSIONS: Bufalin not only inhibited the growth of colon cancer SW620 cells, but also induced apoptosis of SW620 cells. Activation of caspase-3, up-regulation of Bax, down-regulation of livin and Bcl-2, as well as inhibition of Jak-stat3 signaling pathway might be the important mechanisms for the bufalin-induced apoptosis. BioMed Central 2012-10-30 /pmc/articles/PMC3534604/ /pubmed/23110625 http://dx.doi.org/10.1186/1477-7819-10-228 Text en Copyright ©2012 Zhu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhu, Zhitu
Li, Enze
Liu, Yangyang
Gao, Yu
Sun, Hongzhi
Ma, Guangyou
Wang, Zhenghua
Liu, Xiaomei
Wang, Qingjun
Qu, Xiujuan
Liu, Yunpeng
Yu, Yunlong
Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title_full Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title_fullStr Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title_full_unstemmed Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title_short Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
title_sort inhibition of jak-stat3 pathway enhances bufalin-induced apoptosis in colon cancer sw620 cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534604/
https://www.ncbi.nlm.nih.gov/pubmed/23110625
http://dx.doi.org/10.1186/1477-7819-10-228
work_keys_str_mv AT zhuzhitu inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT lienze inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT liuyangyang inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT gaoyu inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT sunhongzhi inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT maguangyou inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT wangzhenghua inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT liuxiaomei inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT wangqingjun inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT quxiujuan inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT liuyunpeng inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells
AT yuyunlong inhibitionofjakstat3pathwayenhancesbufalininducedapoptosisincoloncancersw620cells